Google's sister company seeks $5 billion to find new medicines with AI

Isomorphic Labs, a company owned by Alphabet, is in talks to raise roughly $5 billion in new funding. Alphabet is the parent company of Google. The money would support the company's work using artificial intelligence to discover new drugs, according to people familiar with the matter, as reported by Bloomberg Technology.

What the company does

Finding a new medicine is slow and costly. Isomorphic Labs is trying to use AI, which means computer programs that learn patterns from large amounts of data, to help with that search. The goal is to speed up the early work of finding drugs that might help patients.

What is not known yet

This is a report of talks, not a finished deal. The material does not say who the investors are, what the company would be worth, or when any agreement could close. The numbers could change, and the talks could fall through.

It also does not say which diseases the company is working on or whether any drug it has helped find is close to testing in people.

Why it matters

A raise of this size would show how much money is flowing into AI for medicine. If the technology does speed up drug discovery, new treatments could someday reach patients sooner. That is a big if, and it would take years to see.

What happens next

The next thing to watch is whether the funding is confirmed and who takes part. Until then, the $5 billion figure is a report from unnamed sources, not an announcement.